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Introduction 
Diseases of the cardiovascular system are the leading cause of death in most 
countries of the world. The epidemiological situation in Moldova is characterized by 
the term “over-mortality” due to cardiovascular diseases, compared to 
economically developed countries.  
 
Purpose 
Study of possible pharmacodynamic effects, mechanisms of action and 
toxicity of metabolic drugs - mildronate based on the molecular structure of 
the pharmaceutical substance.  
  
Material and methods 
An open randomized clinical trial was performed that included 160 patients with 
CPI (117 men and 43 women) with a mean age of 59.26 ± 0.74 years. 142 patients 
had stable angina pectoris from different functional classes, and 21 - unstable 
angina pectoris. The control group included 30 practically healthy people. The 
observation period was 6 weeks.  
 
Results 
There was an improvement in the repolarization phase in the form of a reduction in 
the depth of the "T" wave from 1.5 mm to 0.2 mm (p<0.05). At the end of the 
observation period, patients treated with mildronate increased exercise tolerance 
from 310.66±24.74 meters to 476.50±43.5 meters (p <0.05). Mildronate provided a 
hemodynamic effect in the form of a decrease in blood pressure - systolic from 
161.76±4.39 mmHg to 143.4±5.13 mm Hg (p<0.05) and diastolic from 95.09±2.88 
mmHg to 87.54±2.52 mmHg (p=0.06). The summary efficacy coefficient of the basic 
therapy was 15.55±4.21%, and of the complex pharmacotherapy with mildronate 
59.16±3.31% (p<0.001), which is actually 4 times higher.   
ConclusionsIn patients with stable exertional angina pectoris, a 4-fold increase in 
the efficacy of pharmacotherapy was added to the addition of mildronate due to the 
more pronounced antianginal effect, improved physical performance, potentiation of 
positive and hypotensive inotropic effects. 
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